|
FDA Finalizes Guidance Supporting Superiority Trials for Acute Bacterial Sinusitis Drugs
Sponsors of clinical studies for antimicrobial drugs to treat acute bacterial sinusitis (ABS) should use superiority trials and demonstrate that the candidate affects the clinical course of the disease, according to finalized FDA guidance on the topic.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives